![]() China Pharma Industry Segmentation by Clinical Trials The number of total deals per year in this sector has increased between 2011 to 2020, with the highest jump seen in 2020, fuelled by COVID-19. The China pharma market size was US$149.8 billion in 2019, and as the innovation gap between China and other countries narrows, it is well positioned to increase its presence in the global market. China has continually sought to make its market more accessible to international drug manufacturers and attract foreign companies by implementing multiple regulatory changes to allow for faster drug approval timelines and clearer guidelines Regulatory Trends: The key regulatory trend impacting the China pharma market is the reforms to attract overseas companies.Technology Trends: The key technology trends impacting the China pharma market are the increasing use of AI in pharma, 5G, and the emerging 3D industry.Macroeconomic Trends – The key macroeconomic trends that will shape the China pharma market are US-China relations and the improvement of the overall health of the people of China.Industry Trends: The key industry trends impacting the China pharma market include the dominance of generics, the expansion of biosimilars, the regenerative medicine sector, and others. ![]() The key trends that are impacting the China pharma market can be classified into industry trends, macroeconomic trends, technology trends, and regulatory trends. The report also provides an overview of key regulatory and market access information, market drivers and barriers, and key players in the Chinese pharma sector.įor more insights on the China pharma market forecast, download a free report sample Key Trends in the China Pharma Market The impact of China on the pharmaceutical industry research report provides an assessment of the major industry, regulatory, macroeconomic, and technological trends shaping the Chinese pharma industry. Recent regulatory reforms and national strategic initiatives are shifting focus from generics towards R&D innovation. The government has identified biopharma as a key industry for economic development. China has the second largest pharma market in the world behind the US. The China pharma market size was US$149.8 billion in 2019 and the market is expected to grow at a CAGR of more than 12% between 20.
0 Comments
Leave a Reply. |